Pancreatic and Biliary Stent Market

Pancreatic and Biliary Stent Market Outlook (2024 to 2034)

Revenue from worldwide sales of pancreatic and biliary stents is calculated at US$ 370.2 million in 2024. A new study by Fact.MR states that the market is projected to expand at a CAGR of 4.6% and reach a value of US$ 583 million by the end of 2034.

Biliary or pancreatic stents are plastic or metal tubes mainly used to determine whether an obstructed bile or pancreatic duct is still open. These stents help prevent pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP) surgery or to treat biliary or pancreatic leaks.

To relieve obstructions within the biliary tree or to address biliary leaks, biliary stenting entails the insertion of tubes, usually made of plastic or metal. This procedure is used for both benign and malignant conditions involving the biliary tract. It is an important intervention, especially when palliative care is required due to advanced malignancies.

Key Market Growth Drivers

• Growing number of endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) procedures that necessitate stent placement and recurrent stenting is the primary driver for market growth.
• Need for ERCP treatments, which include stenting for biliary obstruction conditions, has been increasing in recent years across the globe.
• Gallstones, biliary strictures, pancreatitis, inflammation of the bile ducts, cysts, trauma, infection, including cirrhosis and hepatitis, and severe liver damage are among the conditions that are causing biliary obstruction. Thus, the need for pancreatic and biliary stents among patients with these disorders is increasing.
• In most cases of biliary obstruction, biliary fistulas, and biliary strictures, pancreatic and biliary stents are used to help drain bile into the digestive tract. In essence, the endoscopic stent insertion options that are currently available are biliary stents.
• Widespread use of biliary stents has resulted in significant advancements, albeit with increased complications such as post-implantation infection and restenosis.
• Surface modification techniques, such as coating with radioactive particles and other methods are gaining popularity to improve the performance of biliary stents. Of these methods, coating has become the main area of interest for researchers hoping to grow the market for biliary stents.

Report Attribute	Detail
Pancreatic and Biliary Stent Market Size (2024E)	US$ 370.2 Million
Forecasted Market Value (2034F)	US$ 583 Million
Global Market Growth Rate (2024 to 2034)	4.6% CAGR
East Asia Market Share (2024E)	11.1%
North America Market Share (2024E)	47.8%
Specialty Clinics Segment Value (2024E)	US$ 111 Million
Key Companies Profiled	Abbott Laboratories; Beckton, Dickson and Company; Medtronic Plc.; Olympus Corporation; CONMED Corporation; Boston Scientific Corporation; Cook Medical Inc.; Merit Medical System; Cardinal Health.

What are the Key Pancreatic and Biliary Stent Market Trends?

“Integration of Advanced Coating Technology Enhancing Patient Outcomes”

Ongoing advancements in materials science present several new opportunities for biliary stent providers. Biliary stents' robust structural design enhances their usefulness and performance. Due to the complexity of the biliary system, complications such as postoperative biliary infection and restenosis persist even though it is an essential intervention in the management of biliary tract diseases.

One potential solution to these issues is the incorporation of coating technology into biliary stents. The innovative creation of functional coatings for biliary stents marks the beginning of a new phase in innovation by providing ways to improve patient outcomes and reduce complications. This creative method not only makes it possible to get around current obstacles but also opens up amazing prospects for stent providers.

What Hindrances Do Pancreatic and Biliary Stent Manufacturers Face?

“Biliary Strictures Exhibiting Higher Risk of Dislodgment Than Malignant Strictures”

Growth of the market is significantly hampered by early complications such as bleeding, infection, and pancreatitis, as well as occlusion from sludge or tissue overgrowth. Different stent types have different dislodgment rates; fully-covered SEMSs have a higher incidence of dislodgment, followed by plastic stents and partially-covered SEMSs.

The market for pancreatic and biliary stents is further restrained by the fact that benign biliary strictures have a higher dislodgment risk than malignant strictures. To fully realize the benefits of biliary stenting procedures, efforts must be made to mitigate these complications.

Country-wise Insights

Developed and developing countries in North America, Asia Pacific, and Europe are witnessing innovations and intervention techniques for the treatment of pancreatic diseases, which is projected to increase the number of pancreatic and biliary surgeries. As a result, rising awareness of stent-based therapies is projected to contribute to the expansion of the pancreatic and biliary stent market size.

What’s Pushing Sales of Pancreatic and Biliary Stents in the United States?

“Increasing Cases of Cholangiocarcinoma”

Attribute	United States
Market Value (2024E)	US$ 156 Million
Growth Rate (2024 to 2034)	5.2% CAGR
Projected Value (2034F)	US$ 260 Million

The United States accounts for 88.2% of pancreatic and biliary stent market share in North America in 2024. Pancreatic cancer is the second most common cancer of the digestive system and the fourth leading cause of cancer-related deaths in the country for both men and women.

• According to the JAMA Network, the United States sees approximately 4,500 new cases of cholangiocarcinoma each year. In addition, 30% to 60% of these tumors are proximal cholangiocarcinomas.

What are the Projections for Pancreatic and Biliary Stent Market Growth in China?

“Availability of Low-Cost Labor and Robust Manufacturing Infrastructure”

Attribute	China
Market Value (2024E)	US$ 17 Million
Growth Rate (2024 to 2034)	3.7% CAGR
Projected Value (2034F)	US$ 25 Million

There are various factors contributing to the growth of the market in China. These include the availability of skilled technicians, inexpensive labor, and a well-developed manufacturing infrastructure in China. Many companies and research and development centers are situated in China for several companies producing pancreatic and biliary stents, including Taewoong Medical. This strategy provides financial benefits for manufacturers, thereby driving market expansion.

Category-wise Insights

Stents are made of plastic or metal, depending on the patient's needs; plastic stents are typically used for temporary relief, while metal stents are used for longer-term care. Biliary sphincterotomy is not always necessary when a single plastic stent or SEMS is inserted, but in some circumstances, it might be. Stents that are frequently used are plastic stents and self-expanding metal stents (SEMS), each of which has a different function during the therapeutic process.

Why are Metal Pancreatic and Biliary Stents Preferred over Other Types?

“Long-Term Management Capabilities of Metal Pancreatic and Biliary Stents”

Attribute	Metal Pancreatic and Biliary Stents
Segment Value (2024E)	US$ 353.6 Million
Growth Rate (2024 to 2034)	4.6% CAGR
Projected Value (2034F)	US$ 552.2 Million

The metal segment is poised to hold a significant market share of 95.5% in 2024. Metal stents are preferred over other types due to their long-term management. The market for biliary stents is growing at a steady pace as a result of the development of stents with anti-migratory, anti-reflux, drug-eluting, and bioabsorbable qualities that overcome the drawbacks of conventional stents and help healthcare providers find novel ways to improve patient care.

Why Do Hospitals Account for a Significant Share of the Market?

“Enhanced Healthcare Infrastructure and Availability of Advanced Treatment Solutions”

Hospitals are estimated to account for 46.9% market share in 2024. The number of hospital procedures for pancreatic disorders in developed nations is projected to increase driven by improved healthcare infrastructure. As a result, both the rise in patients being admitted and the availability of a successful treatment are projected to lead to an increase in hospital visits.

Several hospitals use endoscopic ultrasound (EUS) for the insertion of stents. This procedure uses detailed images of the bile duct obtained through an endoscope equipped with a small ultrasound probe inserted through the mouth and down the throat to precisely position the stent. The implementation of this approach facilitates the accurate and efficient placement of biliary stents to improve patient outcomes and augment hospital capabilities to enhance their biliary care services.

Company Developments

• A key player in the pancreatic and biliary stent market, Taewoong Medical Co. Ltd. (Leading Korean gastrointestinal stent manufacturer), was acquired by Olympus in January 2024.
• WallFlex Biliary RX Fully Covered Stent, manufactured by Boston Scientific in the United States, is the only fully covered self-expandable metal stent (FCSEMS) approved by the United States Food and Drug Administration for the treatment of benign biliary stricture (BBS) caused by chronic pancreatitis, with an indwell time of up to 12 months.

Fact.MR provides detailed information about the price points of key manufacturers of pancreatic and biliary stents positioned across the world, sales growth, production capacity, and speculative technological expansion, in this new market report.

Segmentation of Pancreatic and Biliary Stent Market Research

• By Product Type :

  • Plastic
  • Metal

• By Application :

  • Benign Biliary Strictures
  • Biliary Leaks
  • Malignant Obstruction
  • Biliary Stones
  • Pancreatic Cancer

• By End User :

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

• By Region :

  • North America
  • Western Europe
  • Eastern Europe
  • Latin America
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa